
    
      Delivering the chemotherapeutic agent in the arterial system through the ophthalmic artery
      transforms the treatment of retinoblastoma from systemic chemotherapy to local chemotherapy.
      Administration of the drug directly to the targeted site thus avoids the complications and
      adverse events associated with toxicity from systemic, rather than local, chemotherapy.
    
  